David Happel - 10 Feb 2026 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role: President & CEO, Director
Signature: /s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol: SGMT
Transactions as of: 10 Feb 2026
Net transactions value: -$64,865
Form type: 4
Filing time: 12 Feb 2026, 16:08:51 UTC
Previous filing: 23 Jul 2025
Next filing: 20 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Happel David	President & CEO, Director	SAGIMET BIOSCIENCES INC., 155 BOVET RD., SUITE 303, SAN MATEO	/s/ Elizabeth Rozek, Attorney-in-Fact	12 Feb 2026	0001623567

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGMT	Series A Common Stock	Sale	$64,865	-12,101	-1.8%	$5.36	677,621	10 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.